Examining Patient Preferences About the IBM Watson Oncology Clinical Decision Support System



Status:Active, not recruiting
Conditions:Breast Cancer, Lung Cancer, Colorectal Cancer, Colorectal Cancer, Cancer, Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:8/26/2018
Start Date:September 15, 2015
End Date:September 2019

Use our guide to learn which trials are right for you!

The purpose of this study is to learn what cancer patients think about IBM Watson Oncology.
IBM Watson Oncology is a computer program designed to help inform oncologists about the best
chemotherapy choices for their patients. The investigators will conduct focus groups with
cancer patients who have received chemotherapy treatment at MSK in order to understand cancer
patients' thoughts about IBM Watson Oncology.


Inclusion Criteria:

- MSKCC patient 18 years or older

- Breast, lung, or colorectal cancer MSK patient as per EMR or clinician judgment having
either:

- Chemotherapeutic adjuvant or neoadjuvant treatment with the first chemo visit
occurring within the past 8 months and primary treatment (i.e., surgery),
occurring within the past 6 months)at MSK

- OR chemotherapeutic treatment for metastatic disease with the first chemo visit
occurring within the past 8 months at MSK

- OR chemotherapeutic treatment through an on-going MSK clinical trial as per
clinician

- Residing in New York metro-area

Exclusion Criteria:

- Non-English speakers because we do not have the resources to conduct and translate the
focus groups into other languages

- Patients who are not or will not receive their cancer care at MSKCC.

- Patient unwilling or unable to provide informed consent
We found this trial at
1
site
1275 York Ave
New York, New York 10021
(212) 639-2000
Principal Investigator: Jada Hamilton, PhD, MPH
Phone: 646-888-0049
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
?
mi
from
New York, NY
Click here to add this to my saved trials